Streetbeat News

Stock Prices

SPGI

S&P Global has updated its fiscal year 2024 revenue growth forecast, increasing it from the previously estimated range of 5.5% - 7.5% to a new range of 6.0% - 8.0%.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:18 am

LUV

Southwest Airlines reported worse-than-expected Q1 financial results, leading to a decline in its share price.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:17 am

SPGI

S&P Global reported Q1 adjusted earnings of $4.01 per share, surpassing the $3.66 estimate, marking a 27.3% increase from last year. Sales reached $3.49B, exceeding the $3.42B estimate, up 10.47% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:15 am

LH

Laboratory Corp (NYSE:LH) reported Q1 2024 earnings of $3.68 per share, surpassing the $3.48 estimate, and sales of $3.177B, exceeding the $3.117B forecast. This represents a 6.36% increase in earnings and a 4.58% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:14 am

ULBI

Ultralife Corporation reported Q1 2024 adjusted EPS of $0.21, surpassing the $0.10 estimate, with sales of $41.927M exceeding the $38.000M forecast. This represents a 31.37% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:13 am

BMY

Bristol Myers Squibb has significantly revised its 2024 adjusted EPS guidance downwards from $7.10-$7.40 to $0.40-$0.70, aligning closely with the consensus estimate of $0.66. This adjustment reflects the impact of recent transactions.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:12 am

KDP

Keurig Dr Pepper has reaffirmed its fiscal year 2024 guidance, expecting mid-single-digit range growth in constant currency net sales and high-single-digit range growth in adjusted diluted EPS.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:09 am

AMBP

Ardagh Metal Packaging (AMBP) reported Q1 2024 adjusted EPS of $0.01, beating the undefined analyst consensus estimate. However, its sales of $1.141B missed the $1.149B estimate, marking a 0.72% miss but a 0.88% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:09 am

NEM

Newmont (NYSE:NEM) reported Q1 2024 adjusted EPS of $0.55, surpassing the $0.36 estimate, with sales of $4.023B exceeding the $3.670B forecast. This represents a 50.17% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:08 am

BMY

Bristol-Myers Squibb (BMY) reported Q1 2024 adjusted EPS of $(4.40), surpassing the $(4.44) estimate, and sales of $11.865B, exceeding the $11.458B estimate. This represents a 314.63% decrease in EPS from last year's $2.05, but a 4.66% increase in sales from $11.337B.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:07 am